Acadia Pharmaceuticals Files 8-K on Shareholder Votes

Ticker: ACAD · Form: 8-K · Filed: May 29, 2025 · CIK: 1070494

Acadia Pharmaceuticals Inc 8-K Filing Summary
FieldDetail
CompanyAcadia Pharmaceuticals Inc (ACAD)
Form Type8-K
Filed DateMay 29, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-vote

Related Tickers: ACAD

TL;DR

Acadia Pharma held a shareholder vote, details to follow.

AI Summary

Acadia Pharmaceuticals Inc. filed an 8-K on May 29, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain specific details about the proposals or the outcome of any votes.

Why It Matters

This filing indicates that Acadia Pharmaceuticals Inc. has held or is holding a vote of its shareholders, which is a standard corporate governance event.

Risk Assessment

Risk Level: low — The filing is a routine corporate disclosure regarding shareholder votes and does not involve significant financial or operational changes.

Key Players & Entities

  • ACADIA PHARMACEUTICALS INC (company) — Registrant
  • May 29, 2025 (date) — Date of Report
  • Delaware (jurisdiction) — State of Incorporation
  • 000-50768 (filing_id) — SEC File Number
  • 06-1376651 (ein) — IRS Employer Identification No.
  • 12830 El Camino Real, Suite 400 (address) — Principal Executive Offices
  • San Diego, California (location) — Principal Executive Offices City and State
  • 92130 (zip_code) — Principal Executive Offices Zip Code
  • (858) 558-2871 (phone_number) — Registrant's Telephone Number

FAQ

What specific matters were submitted to a vote of Acadia Pharmaceuticals Inc.'s security holders?

The filing states that it is a report on "Submission of Matters to a Vote of Security Holders" but does not detail the specific proposals voted upon.

When was the report filed with the SEC?

The report was filed on May 29, 2025.

What is the company's principal executive office address?

The principal executive offices are located at 12830 El Camino Real, Suite 400, San Diego, California, 92130.

What is the company's telephone number?

The company's telephone number, including area code, is (858) 558-2871.

In which state was Acadia Pharmaceuticals Inc. incorporated?

Acadia Pharmaceuticals Inc. was incorporated in Delaware.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 29, 2025 regarding ACADIA PHARMACEUTICALS INC (ACAD).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.